戻る Agenda
Session 1 - Modern Clinical Trials in APAC: From Concept to Implementation and Regulatory Adoption
Session Chair(s)
Karin Markgraf
Head of Regulatory Affairs Asia Pacific, Merck Healthcare, Singapore
Martin Lim, MBA, MS
Co-Founder and CEO, ONWARD Health Research, Singapore
Sandy Chan
Associate Director, Regulatory Policy & Intelligence Lead- Asia Pacific, Johnson & Johnson, Singapore
Hueybee Pey
Senior Director, Project Leadership, Parexel, Singapore
Speaker(s)
Eugene Gan
Senior Director, Singapore Clinical Research Insititute, Singapore
Ana Miros
Partner, CFGI, Singapore
Anita Lim
Interim Deputy Director, Innovation Accelerator, Science, Research & Innovation, Medicines and Healthcare products Regulatory Agency (MHRA)., United Kingdom
Dorothee Grimald
JAPAC Regulatory Policy Director, AMGEN, Singapore
Parasar Pal
Head of Clinical Measurement Sciences India, Merck, India
Cathelijne De Gram, PharmD, RAC
Regulatory Policy Director, J&J, Netherlands